J Gassler, W Kobayashi, I Gáspár, S Ruangroengkulrith… - Science, 2022 - science.org
Life begins with a switch in genetic control from the maternal to the embryonic genome during zygotic genome activation (ZGA). Despite its importance, the essential regulators of …
A Ahmed, C Schmidt, T Brunner - Frontiers in immunology, 2019 - frontiersin.org
Glucocorticoids (GCs) are steroid hormones predominantly produced in the adrenal glands in response to physiological cues and stress. Adrenal GCs mediate potent anti-inflammatory …
S Michalek, T Goj, AP Plazzo, B Marovca… - EMBO …, 2022 - embopress.org
Nuclear receptors are transcription factors with important functions in a variety of physiological and pathological processes. Targeting glucocorticoid receptor (GR) activity …
C Li, J Dong, Z Han, K Zhang - Oncology research, 2017 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are reportedly involved in gastric cancer development and progression. In particular, miR-219-5p has been reported to be a tumor-associated miRNA …
HB Kramer, CF Lai, H Patel, M Periyasamy… - Nucleic acids …, 2016 - academic.oup.com
Abstract Liver receptor homologue 1 (LRH-1) is an orphan nuclear receptor that has been implicated in the progression of breast, pancreatic and colorectal cancer (CRC). To …
Nuclear receptor liver receptor homolog-1 (LRH-1, NR5A2) is a lipid-regulated transcription factor and an important drug target for several liver diseases. Advances toward LRH-1 …
R Qu, S Hao, X Jin, G Shi, Q Yu, X Tong, D Guo - Gene, 2018 - Elsevier
Deregulation of microRNA (miRNA) has been suggested as a critical event in colon cancer development and progression. Recent studies have suggested that miR-374b is a novel …
J Schwaderer, TS Phan, A Glöckner, J Delp… - Cell death & …, 2020 - nature.com
Abstract Liver receptor homolog-1 (LRH-1, Nr5a2) is an orphan nuclear receptor mainly expressed in tissues of endodermal origin, where its physiological role has been extensively …
Q Zhang, S Zhao, X Pang, B Chi - Oncology reports, 2016 - spandidos-publications.com
MicroRNAs (miRs) have emerged as prospective tools for human cancer therapy, including hepatocellular carcinoma (HCC) therapy. Previous studies have suggested that miR-381 …